Does cancer immunotherapy work better in men than women?
18 May, 2018Male cancer patients may benefit more from immunotherapy than female patients.
Bowel cancer researcher focuses on molecular analysis
14 May, 2018Professor Mark Molloy has been appointed the inaugural Lawrence Penn Chair of Bowel Cancer Research at the University of Sydney.
Improved diagnosis for glaucoma, the 'sneak thief of sight'
09 May, 2018Researchers have bridged a key knowledge gap in the diagnosis of glaucoma, allowing observable damage to the optic nerve to be accurately linked to vision loss.
Cancer Australia releases 'stage at diagnosis' data
30 April, 2018The landmark data reveals the extent and spread of the top five incidence cancers at diagnosis across four stages of severity.
Nanoscale sensor detects cytokine
26 April, 2018A newly developed sensor can detect signalling molecules — called cytokines — that operate in the living brain.
How much does cancer cost the Australian economy?
09 April, 2018Experiencing cancer is tough for any patient, as well as their family and friends. But it seems that cancer is also not great for the Australian economy.
Optimum treatment for advanced melanoma patients revealed
05 April, 2018Researchers now have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Why are rheumatoid arthritis patients at risk of heart disease?
29 March, 2018Treating rheumatoid arthritis patients with a high-density lipoprotein (HDL) may limit their risk of developing heart disease, according to Melbourne researchers.
Less invasive glaucoma treatment gets approval
27 March, 2018A surgical treatment for glaucoma that involves implantation of a microfistula tube has been approved for general use in Australia.
Drug delays disability in secondary progressive MS
27 March, 2018A new drug is said to slow the progression of disability in secondary progressive multiple sclerosis (MS), according to a double-blind, randomised, phase III trial.
Alliance Agreement to advance laser-based cancer treatment
27 March, 2018The Hudson Institute and Invion have signed a Research & Development Alliance Agreement in order to advance the latter's cancer treatment technology, Photosoft.
Blood cancer biomarker discovered
26 March, 2018Scientists have discovered a biomarker that could help to unlock the medical mystery behind multiple myeloma — an untreatable blood cancer that affects mostly older Australians.
Human antibody found to prevent malaria in mice
22 March, 2018US scientists have discovered a human antibody that protects mice from infection with the deadliest malaria parasite, Plasmodium falciparum.
Numedico, NY med school collaborate for ovarian cancer
16 March, 2018SA-based Numedico Technologies and NY-based Icahn School of Medicine at Mount Sinai have partnered to improve early detection of endometrial and ovarian cancers.
Clarivate Analytics partners with IP Australia
01 March, 2018Clarivate Analytics has partnered with IP Australia by providing its enhanced patent data to augment its Source IP database.
